About
Andreas Lindblom is the co-founder and Managing Partner at Sciety. He has over ten years of experience investing in Nordic life science. He discussed Sciety's growth strategy through market turbulence and key questions investors should ask before committing capital on the BioStock Health and Wealth podcast. He also stated that Neogap has a unique therapeutic approach in T-cell therapy, combining personalised treatment with a scalable manufacturing process.
Sign up to see Andreas Lindblom's full profile
Access investment thesis, focus areas, bio, and contact details for Andreas Lindblom and 22,000+ other VC professionals.
Sciety
Stockholm, SE